{
    "title": "111_hr6389",
    "content": "The Act may be cited as the \"Prostate Research, Outreach, Screening, Testing, Access, and Treatment Effectiveness Act of 2010\" or the \"PROSTATE Act\". Congress finds that prostate cancer is a significant health issue, with high mortality rates among men. There are disparities in the disease's impact, particularly affecting African-Americans and underserved rural populations. Prostate cancer mortality rates are higher in underserved rural populations compared to urban areas. Telehealth can be utilized to improve access to quality care for prostate cancer. Urologists play a key role in diagnosing and treating prostate cancer patients. Many unanswered questions remain regarding disparities in disease etiology, access to care, and community education and awareness. Prostate cancer causes are unknown, leading to difficulty in distinguishing between aggressive and indolent forms early on. This results in significant overtreatment, with no durable treatments once the cancer has metastasized. A large percentage of cases may be clinically indolent, leading to overdiagnosis and overtreatment. Improved tests could reduce physical, psychological, financial, and emotional trauma for patients and save billions in healthcare costs. Prostate cancer research and health care programs should be coordinated to improve accountability and encourage the translation of research into practice. This will help identify best practices for effective prevention, diagnosis, and treatment of the disease, ultimately saving billions in healthcare costs. The text chunk \"SEC. 3. PROSTATE CANCER COORDINATION AND EDUCATION.\" focuses on the need for coordination and education in prostate cancer research and health care programs. The Prostate Cancer Task Force, established by the Secretary of Veterans Affairs, in collaboration with the Secretary of Defense and the Secretary of Health and Human Services, aims to develop a summary of advances in prostate cancer research and compile best practices for broader adoption in health care programs. They also consider advocating for guidance to enable screening of men over a certain age. The Prostate Cancer Task Force, established by the Secretary of Veterans Affairs, aims to develop a summary of advances in prostate cancer research and compile best practices for adoption in health care programs. They consider advocating for guidance to enable screening of men over age 74 on a case-by-case basis, taking into account quality of life and family history. They also share and coordinate information on Federal research and health care program activities to improve research, identify gaps, promote translation of research into practice, and maximize collaboration opportunities. The Prostate Cancer Task Force aims to develop a comprehensive interagency strategy for collaborative research and health care programs related to prostate cancer. This includes innovative approaches to address knowledge gaps, outline key research questions, and evaluate factors related to the etiology of the disease. The Prostate Cancer Task Force aims to address knowledge gaps, outline research questions, and develop a coordinated message for screening and treatment. Recommendations will be submitted to improve research and health care programs within two years. The Prostate Cancer Task Force aims to improve research and health care programs by ensuring strategic planning, eliminating duplication, and involving the public in decisions related to prostate cancer research and health care. The Prostate Cancer Task Force seeks to enhance public participation in decisions regarding prostate cancer research and health care programs, disseminate information effectively, expand partnerships between public and private entities for collaborative research and health care delivery, and assess cost savings and efficiencies to recommend further expansion of efforts. The Prostate Cancer Task Force aims to coordinate efforts, recommend priority action items, and determine funding needs for implementing recommendations. Task force members include representatives from relevant federal agencies to ensure a unified message on prostate cancer screening and treatment. The Prostate Cancer Task Force appoints expert advisory panels from relevant federal agencies and medical communities to coordinate a uniform message on prostate cancer screening and treatment. The Prostate Cancer Task Force, comprised of experts in prostate cancer diagnosis and treatment, convenes meetings at least twice a year to discuss recommendations for Congress. The Federal Advisory Committee Act applies to the task force, with exceptions outlined. The Prostate Cancer Task Force is subject to the Federal Advisory Committee Act, with an exception regarding termination of advisory committees. SEC. 4. PROSTATE CANCER RESEARCH. The Secretary of Veterans Affairs, in coordination with the Secretaries of Defense and of Health and Human Services, shall establish a program to intensify prostate cancer research. This program aims to develop advances in diagnostic methods, understand the disease's causes, and focus on lifestyle factors affecting different ethnic groups. The Prostate Cancer Scientific Advisory Board is established to improve prevention efforts, expand basic research, identify novel agents for treatment, establish clinical registries, and assess appropriate imaging modalities. The Office of the Chief Scientist of the FDA established a Prostate Cancer Scientific Advisory Board to accelerate research data sharing and the movement of new medicines to patients. The Underserved Minority Grant Program aims to address disparities in prostate cancer incidence and mortality rates, barriers to care, and clinical trial participation for minorities and those with a family history of the disease. The Prostate Cancer Scientific Advisory Board aims to address disparities in care for minorities and those with a family history of the disease by focusing on barriers to access and participation in clinical trials, needed outreach and educational efforts, and appropriate utilization of imaging modalities. SEC. 5. TELEHEALTH AND RURAL ACCESS PILOT PROJECT. The Secretary of Veterans Affairs will establish telehealth pilot projects to analyze clinical outcomes and cost effectiveness in underserved populations, including African-Americans, Latin-Americans, American Indians, and rural areas. The projects aim to improve specialist care coordination, utilize physician extender teams, and enhance tumor board counseling for patients. Eligible entities will be selected to participate in these pilot projects. The Secretary will prioritize eligible entities in medically underserved areas, including African-Americans, Latin-Americans, and Indian Health Service facilities, for telehealth pilot projects. The evaluation will focus on the effective delivery of care for prostate cancer using telehealth services in underserved and tribal areas, improving nonmedical and nonspecialized providers' capacity. The Secretary will prioritize medically underserved areas, including African-Americans, Latin-Americans, and Indian Health Service facilities, for telehealth pilot projects focusing on improving nonmedical and nonspecialized providers' capacity to deliver prostate cancer care. The evaluation will also explore innovative medical home models with collaboration between urologists, oncologists, radiologists, and primary care teams, as well as the use of telehealth services and tumor boards for better patient counseling. The Secretary will submit a report to Congress on the outcomes of telehealth pilot projects, including cost savings and recommendations for expanding telehealth services. SEC. 6. EDUCATION AND AWARENESS. The Secretary of Veterans Affairs will develop a national education campaign for prostate cancer, focusing on encouraging men to seek screening. The campaign will address racial disparities and target communities with higher incidence rates. Grants will be awarded to nonprofit entities to support the campaign. The Secretary will award grants to nonprofit entities for testing outreach strategies in a national campaign for prostate cancer education. Authorization of appropriations for fiscal years 2011 through 2015 to carry out the Act."
}